Please assess the completion status of the following clinical trial:

Trial Title: Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Treatment-naive, genotype 1 only, compensated, chronic hepatitis C infected Caucasian or African-American patients~* Body weight greater than 61 kg and not more than 87.3 kg~* HCV RNA greater than 2 million copies/mL~* Elevated measured or historical alanine aminotransferase~* Hemoglobin at least 12.0 g/dL for females and at least 13.0 g/dL for males~* Calculated creatinine clearance greater than 70 mL/min~Exclusion Criteria:~* Cirrhosis of the liver~* Alanine aminotransferase greater than 3 times the upper limit of normal~* Severe neuropsychiatric disorders~* History or clinical manifestations of significant metabolic, hematological, pulmonary, ischemic, or unstable heart disease, gastrointestinal, neurological, renal, urological, endocrine, ophthalmologic disorders including severe retinopathy, or immune mediated disease~* Other co-morbid chronic viral infections including hepatitis B and the human immunodeficiency virus (HIV)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).